However, since the blood-based discriminators (such as hypertriglyceridemia, APOB, TRIG, LDLC, and HbA1c) are common denominators for metabolic diseases, these are poor biomarkers for carotid atherosclerosis on their own. Here, APOB is linked to hypertriglyceridemia.